GP2015, a proposed etanercept biosimilar: Pharmacokinetic similarity to its reference product and comparison of its autoinjector device with prefilled syringes

The Concise Guide to PHARMACOLOGY 2015/16: Overview

(2015) Stephen PH Alexander et al.   BRITISH JOURNAL OF PHARMACOLOGY

Totality of the evidence at work: The first U.S. biosimilar

(2015) J. Holzmann et al.   EXPERT OPINION ON BIOLOGICAL THERAPY

The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands

(2015) Christopher Southan et al.   NUCLEIC ACIDS RESEARCH

Efficacy, safety and usability of secukinumab administration by autoinjector/pen in psoriasis: a randomized, controlled trial (JUNCTURE)

(2014) C. Paul et al.   JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY

Influence of antibodies against infliximab and etanercept on the treatment effectiveness of these agents in Japanese patients with rheumatoid arthritis

(2014) Motoaki Hoshino et al.   Modern Rheumatology

The State of the Art in the Development of Biosimilars

(2012) Mark McCamish et al.   CLINICAL PHARMACOLOGY & THERAPEUTICS

Comparison of patient satisfaction with two different etanercept delivery systems

(2012) U. Müller-Ladner et al.   ZEITSCHRIFT FUR RHEUMATOLOGIE

Subcutaneous adipose tissue thickness in adults - correlation with BMI and recommendations for pen needle lengths for subcutaneous self-injection

(2011) Burkhard Ludescher et al.   CLINICAL ENDOCRINOLOGY

Patient satisfaction with injection devices: a randomized controlled study comparing two different etanercept delivery systems in moderate to severe psoriasis

(2011) C. Paul et al.   JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY

Maximizing patient adherence for optimal outcomes in psoriasis

(2011) A Bewley et al.   JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY